Pongo Peng
About Pongo Peng
Pongo Peng is the BU Head of the Virology Business Unit at Bristol-Myers Squibb and a General Manager at Gilead Sciences.
Current Positions
Pongo Peng holds dual roles at prominent pharmaceutical companies. As of now, he is the General Manager at Gilead Sciences, a position he started in August 2014. Parallel to this, he serves as the BU Head of the Virology Business Unit at Bristol-Myers Squibb, based in New York, New York, United States.
Education and Qualifications
Pongo Peng is an alumnus of China Medical University (TW), where he studied for five years from 1987 to 1992. He earned his Bachelor's degree, specifically a Bachelor of Science. This academic background laid the foundation for his career in the pharmaceutical industry, particularly in virology.
Professional Experience at Gilead Sciences
Pongo Peng embarked on his tenure at Gilead Sciences in August 2014, assuming the role of General Manager. With over nine years of experience in a managerial capacity, Peng has contributed significantly to the company's operations, overseeing various strategic initiatives and day-to-day business activities.
Role in Virology at Bristol-Myers Squibb
At Bristol-Myers Squibb, Pongo Peng applies his expertise as the BU Head of the Virology Business Unit. His extensive experience in this field means he plays a critical role in guiding the virology unit, focusing on developing and managing virology-related products and initiatives.